Damn it! CRSP was down big -- I'm up here in the country on my wife's laptop... In the city i would of spotted this.. Crispr Stock Whipsaws Lower After FDA Approves Gene-Editing Treatment Shares of Crispr Therapeutics had a volatile day on Friday after the Food and Drug Administration approved the company's groundbreaking gene-editing treatment for sickle cell disease. CRSP stock rallied ahead of the news, but shares then fell sharply in late morning trades. TheFDA approvedthe treatment thatCrispr developedbased on its gene-editing technology known as CRISPR.Vertex Pharmaceuticals(VRTX) co-developed the treatment. "Gene therapy holds the promise of delivering more targeted and effective treatments, especially for individuals with rare diseases where the current treatment options are limited," Nicole Verdun, M.D., director of the Office of Therapeutic Products at the agency's Center for Biologics Evaluation and Research,said in a statement. In November,the U.K.'s Medicines and Healthcare products Regulatory Agencyapproved the Crisprtreatmentfor patients age 12 and older with blood diseases known as sickle cell disease or beta thalassemia. CRSP stock surged on the news, and is up nearly 50% year to date. CRSP stock was last trading down 11% at 62.05. Crispr has been trading around a 72 cup-base buy point.
Vz I have an old OLLIE buy from me in the $50's but it's long gone// what price did you buy at and where is the buy call? I can't find it. Would love to use this as an example because it is non tech.
Likewise I can only find this brief throw away line nothing about you buying RILY or recommending we buy it. Where is the RILY buy? I know you paper traded ESTC (my idea stk) and AMZN should I even look-- HOW IS YOU HAVE NOTHING WHEN I CHECK!!!
15 consecutive winners.. 15 weeks in a Row. What will the next GBA STOCK OF THE WEEK BE-? LET'S LET VAN CALL IT!
!!-> Vertex and Crispr announce FDA approval of Casgevy for sickle cell diseaseBluebird Bio » 12:57 VRTX, CRSP, BLUE